These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
44 related items for PubMed ID: 1480103
1. A new proteinase degrading type IV collagen. Yamagishi Y, Tsuda M, Tsuda T, Yamamura M. Matrix Suppl; 1992; 1():93-4. PubMed ID: 1480103 [No Abstract] [Full Text] [Related]
2. Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells. Zucker S, Moll UM, Lysik RM, DiMassimo EI, Schwedes JW, Liotta LA. Matrix Suppl; 1992; 1():411. PubMed ID: 1480078 [No Abstract] [Full Text] [Related]
3. Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Morodomi T, Suzuki K, Sasaguri Y, Morimatsu M, Nagase H. Matrix Suppl; 1992; 1():87-8. PubMed ID: 1480100 [No Abstract] [Full Text] [Related]
4. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Karakiulakis G, Papanikolaou C, Jankovic SM, Aletras A, Papakonstantinou E, Vretou E, Mirtsou-Fidani V. Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942 [Abstract] [Full Text] [Related]
5. Desmoplastic response in scirrhous gastric carcinoma: imbalance between collagen synthesis and degradation. Matsui H, Kubochi K, Shimada A, Hasumi A. Anticancer Res; 2000; 20(6C):4733-8. PubMed ID: 11205209 [Abstract] [Full Text] [Related]
6. The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B. O'Farrell TJ, Pourmotabbed T. Arch Biochem Biophys; 1998 Jun 01; 354(1):24-30. PubMed ID: 9633594 [Abstract] [Full Text] [Related]
7. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK. J Cell Physiol; 1993 Dec 01; 157(3):644-9. PubMed ID: 8253876 [Abstract] [Full Text] [Related]
8. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion. Tomita M, Koike H, Han GD, Shimizu F, Kawachi H. Clin Exp Nephrol; 2004 Mar 01; 8(1):17-26. PubMed ID: 15067512 [Abstract] [Full Text] [Related]
10. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M. Oncol Res; 1999 Mar 01; 11(1):17-31. PubMed ID: 10451028 [Abstract] [Full Text] [Related]
11. Synthesis and degradation of basement membranes in benign and malignant salivary gland tumours. A study by in situ hybridization. Soini Y, Autio-Harmainen H. J Pathol; 1993 Jul 01; 170(3):291-6. PubMed ID: 8133403 [Abstract] [Full Text] [Related]
12. Purification and characterization of a collagenolytic enzyme produced by Rathayibacter sp. strains isolated from cultures of Clavibacter michiganensis subsp. michiganensis. Labadie J, Hébraud M. J Appl Microbiol; 1997 Feb 01; 82(2):141-8. PubMed ID: 12452587 [Abstract] [Full Text] [Related]
13. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Dittmann KH, Lottspeich F, Ries C, Petrides PE. Exp Hematol; 1995 Feb 01; 23(2):155-60. PubMed ID: 7828672 [Abstract] [Full Text] [Related]
14. Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia. Monsky WL, Kelly T, Lin CY, Yeh Y, Stetler-Stevenson WG, Mueller SC, Chen WT. Cancer Res; 1993 Jul 01; 53(13):3159-64. PubMed ID: 8391388 [Abstract] [Full Text] [Related]
15. Purification and characterization of collagenolytic proteases from the hepatopancreas of northern shrimp (Pandalus eous). Aoki H, Ahsan MN, Matsuo K, Hagiwara T, Watabe S. J Agric Food Chem; 2003 Jan 29; 51(3):777-83. PubMed ID: 12537457 [Abstract] [Full Text] [Related]
16. The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity. Schnierer S, Kleine T, Gote T, Hillemann A, Knäuper V, Tschesche H. Biochem Biophys Res Commun; 1993 Mar 15; 191(2):319-26. PubMed ID: 8460992 [Abstract] [Full Text] [Related]
17. [MMP-2 expression (type IV collagenase) in gastric cancer]. Sundblad A, Ricci L. Acta Gastroenterol Latinoam; 1998 Mar 15; 28(4):287-90. PubMed ID: 10347682 [Abstract] [Full Text] [Related]
18. High molecular mass type i.v. collagen-specific metalloprotease from human carcinoma tissue. Tsuda M, Yamagishi Y, Katsunuma T. FEBS Lett; 1988 May 09; 232(1):140-4. PubMed ID: 3366242 [Abstract] [Full Text] [Related]
19. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Millichip MI, Dallas DJ, Wu E, Dale S, McKie N. Biochem Biophys Res Commun; 1998 Apr 17; 245(2):594-8. PubMed ID: 9571200 [Abstract] [Full Text] [Related]
20. Myocardial collagenase: purification and structural characterization. Tyagi SC, Cleutjens JP. Can J Cardiol; 1996 Feb 17; 12(2):165-71. PubMed ID: 8605638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]